1. Home
  2. BCDA vs YGMZ Comparison

BCDA vs YGMZ Comparison

Compare BCDA & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.44

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

YGMZ

MingZhu Logistics Holdings Limited

HOLD

Current Price

$0.02

Market Cap

341.4K

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
YGMZ
Founded
N/A
2002
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
341.4K
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BCDA
YGMZ
Price
$1.44
$0.02
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
64.8K
23.9M
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$31,172,395.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.02
52 Week High
$3.20
$24.64

Technical Indicators

Market Signals
Indicator
BCDA
YGMZ
Relative Strength Index (RSI) 54.71 34.84
Support Level $1.36 $0.07
Resistance Level $1.50 $0.08
Average True Range (ATR) 0.07 0.03
MACD 0.01 -0.05
Stochastic Oscillator 72.35 0.20

Price Performance

Historical Comparison
BCDA
YGMZ

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.

Share on Social Networks: